Empowering Real-world Evidence Analysis Through Riskbased De-identification
Clinical trials produce vast amounts of incredibly valuable data that, outside the initial research objectives, is not being sufficiently leveraged,…
Clinical trials produce vast amounts of incredibly valuable data that, outside the initial research objectives, is not being sufficiently leveraged,…
Whilst obviously part of the African continent, North Africa is very definitely its own distinct region, very much divided from…
This cardiovascular medical devices watch column was established at the beginning of this year. However, owing to various changes in…
Chris Watson, Director of Product Strategy for Exco InTouch, explains how electronic clinical outcomes assessment (eCOA) providers are facing heightened…
Regina Ballinger, Senior Manager of Regulatory Intelligence with Thomson Reuters, shares her views on what is known as FDA’s “Statute.”…
The tried and trusted imaging modalities in the preclinical researcher’s toolkit have undergone an evolution over recent years and a…
Statistical Monitoring and Key Risk Indicators could be the Answer for Risk-based Monitoring The industry is at a crossroads when…
Explosive human population growth and international travel, combined with a shrinking habitat for animal species and increased interaction between humans…
Launching a new clinical study is an exciting stage of product development. There is tremendous hope that a new drug…
Biosimilars have important cost benefits to offer the overall healthcare system, and they give access to treatment for patients with…